Spectra254, a developer of high-power, easy-to-use, affordable UVC light decontamination systems, announces that it will speak on the topic of “Advancing UVC Technology for Better Health,” at IDWeek 2014, a four-day conference in Philadelphia in October that focuses on the latest science and bench-to-bedside approaches in prevention, diagnosis, treatment and epidemiology of infectious diseases.
Spectra254’s founder and CEO, George Lichtblau, will speak on Friday, Oct. 10, 2014 at 11:15 a.m. in Learning Lounge 2, Booth 674 on the tradeshow floor at the Pennsylvania Convention Center. Lichtblau’s presentation will cover the benefits of UVC decontamination in healthcare facilities and how UVC systems can protect healthcare facilities from the cost of healthcare-acquired infections.
“HAI’s have been identified as a serious public health risk by the Centers for Disease Control and Prevention,” says Lichtblau. “There is a proven cost-to-benefit ratio gained by healthcare facilities that have deployed UVC as an addition to standard cleaning methods to eliminate the presence of pathogens such as C. difficile, MRSA, HIV, norovirus and salmonella.”
IDWeek is the annual meeting of the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA) and the Pediatric Infectious Diseases Society (PIDS). It will be held Oct. 8-12, 2014. Last year IDWeek drew more than 6,600 participants, mainly healthcare professionals in infectious diseases and healthcare epidemiology and prevention. Attendees included researchers, clinicians, quality and patient safety practitioners, epidemiologists, and public health officials.
In addition to presenting at IDWeek 2014, Spectra254 will display several products, including the Spectra 1100, the Spectra 500 and the RDS-30. Spectra254 is the only company that offers multiple solutions for healthcare facilities, including full-scale devices that decontaminate an entire hospital room or a small unit that can decontaminate a tablet. All of these products will be on display in Booth 224.
The Spectra 1100 series features four high-intensity, custom-made lamps that broadcast a high output of UVC light to virtually every surface in the area being treated to kill pathogens such as C. difficile, MRSA, HIV, norovirus and salmonella. When coupled with the Spectra254 Touch Pad Interface, users can collect and easily export data on the use of the Spectra 1100, including date and start time of the system, cycle time and status to create a comprehensive log for management.
Spectra254 manufactures mobile systems that can decontaminate a space within 5 to 15 minutes, and provides a “green” supplement to the typical use of harsh chemicals. A recent study conducted by the Department of Hospital Epidemiology and Infection Control at Johns Hopkins Medicine in Baltimore showed the Spectra 1000 series is highly effective in killing three major healthcare-acquired pathogens. The device was tested in an unoccupied, fully furnished intensive care hospital room and bathroom.
The company’s systems are manufactured and assembled in a U.S.-based ISO 9000 facility that meets or exceeds the quality assurance standards outlined by International Organization of Standards.
Source: Spectra254
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
Clean Hospitals Corner With Alexandra Peters, PhD: The Issues Around Outsourcing
November 7th 2024Outsourcing environmental hygiene in health care facilities offers cost benefits but often compromises quality. Effective oversight, training, and standards are essential for ensuring patient safety.
Strengthening Defenses: Integrating Infection Control With Antimicrobial Stewardship
October 11th 2024Use this handout to explain the basics of why infection prevention and control and antimicrobial stewardship are essential and how the 2 fields must have a unified approach to patient and staff safety